All eyes on healthcare as UK reacts to tax regime
This article was originally published in Clinica
Executive Summary
The UK government is facing calls to bring forward a review of the business tax regime, due to take place later this year, amid concern that it might be pushing away some of the most important UK-based companies. The warnings from industry observers, including the influential Confederation of British Industries (CBI), came as pharmaceutical giant Shire and other major firms announced plans to relocate to Ireland.
You may also be interested in...
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.
Incyte Hopes To Augment Immune/Inflammation Pipeline With Escient Deal
Incyte will pay $750m to acquire privately held Escient and its first-in-class oral antagonists of Mas-related G protein-coupled receptors X2 and X4.